Susan Berger, MD
Rheumatology · Annapolis, MDNPI 1205879111
Payments from drug & device makers
Across 569 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$2K
- Johnson & Johnson$1K
- Novartis$1K
- Lilly USA, LLC$898
- Pfizer$634
- plus $5K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 99 | $1,678 |
| AbbVie | 112 | $1,547 |
| Johnson & Johnson | 48 | $1,113 |
| Novartis | 42 | $1,019 |
| Lilly USA, LLC | 34 | $898 |
| Pfizer | 38 | $634 |
| UCB, Inc. | 42 | $626 |
| AstraZeneca(2 entities) | 19 | $452 |
| E.r. Squibb & Sons, L.L.C. | 21 | $428 |
| Boehringer Ingelheim | 11 | $391 |
| ANI Pharmaceuticals, Inc. | 21 | $355 |
| Sobi, Inc | 10 | $314 |
| Progentec Diagnostics, Inc. | 1 | $308 |
| GSK | 11 | $234 |
| Mallinckrodt Enterprises LLC | 8 | $222 |
| Radius Health, Inc. | 6 | $192 |
| Aurinia Pharma U.S., Inc. | 6 | $151 |
| Mallinckrodt Hospital Products Inc. | 4 | $117 |
| Fresenius Kabi USA, LLC | 4 | $115 |
| Sanofi | 5 | $107 |
| Invivyd Inc | 4 | $92 |
| Janssen Scientific Affairs, LLC | 1 | $89 |
| Sandoz | 3 | $76 |
| Hikma Pharmaceuticals USA | 4 | $73 |
| Bristol Myers Squibb | 4 | $64 |
| Genentech USA, Inc. | 3 | $52 |
| US Oncology Corporate, Inc. | 1 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Cumberland Pharmaceuticals, Inc. | 1 | $26 |
| Biocon Biologics Inc | 1 | $25 |
| Tonix Medicines, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$11,522 in reported general payments places this provider in the 65th percentile of 173 rheumatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Annapolis
- Ashok JacobAnnapolis$32K
- Mariam AmeriAnnapolis$22K
- Heidi SamiAnnapolis$13K
- Steven KleinHagerstown$3.4M
- Herbert BarafWheaton$1.4M
- Paul DemarcoWheaton$1.4M
- Thomas Grader BeckBaltimore$1.2M
- Michelle PetriBaltimore$1.1M
- Laura HummersBaltimore$1M
- Alan MatsumotoWheaton$720K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.